companiesSEC EDGAR
BridgeBio Oncology Therapeutics, Inc.
SEC EDGAR published this disclosure on 2026-09-08. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-385225
cik1869105
company nameBridgeBio Oncology Therapeutics, Inc.
form8-K